WEISBLUM ERIC (CHIEF EXECUTIVE OFFICER) purchased 0.2% of their position (330.00 shares) of SILO PHARMA, INC. on the open market
Open‑market purchase worth $889.90 — a small addition. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 12/20/2022ACC: 0001213900-22-081513
DirectorOfficer· CHIEF EXECUTIVE OFFICER
Since Apr 2020
+330.00
Net shares
Net buyer
$889.90
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
330.00 acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+200.00
Price / share
$2.68
Trade value
$536.30
% of position
0.1%
12/19/2022
154.52K→154.72K
Common Stock
Direct
Shares
+130.00
Price / share
$2.72
Trade value
$353.60
% of position
0.1%
12/20/2022
154.72K→154.85K
Total
Net shares
+330.00
Net value
$889.90
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 12/19/2022 | P · Purchase | +200.00 | $2.68 | $536.30 | 0.1% | 154.52K | 154.72K |
| Common Stock Direct | 12/20/2022 | P · Purchase | +130.00 | $2.72 | $353.60 | 0.1% | 154.72K | 154.85K |
| Total | +330.00 | $889.90 | ||||||
Derivative Transactions0
No derivative transactions reported